A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2001
12/20/2001	WO2001035937A3 Lipid complex of alkycyclines
12/20/2001	WO2001034120B1 Apparatus and method for preparing microparticles using in-line solvent extraction
12/20/2001	WO2001032230A3 A polymer micelle as monolayer or layer-laminated surface
12/20/2001	WO2001030391A3 Pharmaceutical composition containing midazolam
12/20/2001	WO2001028511A3 Selective removal of contaminants from a surface using magnets
12/20/2001	WO2001022969A3 Vasopressin agonist formulation and process
12/20/2001	WO2000024452A9 Systems and compounds for drug delivery to interstitial regions of the myocardium
12/20/2001	WO1997049394A3 Sold oral dosage forms of valsartan
12/20/2001	US20010053897 Hydrogels containing substances
12/20/2001	US20010053801 Inverse latexes based on white mineral oil, squalene or hydrogenated polyisobutene, cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions containing them
12/20/2001	US20010053791 Glycogen phosphorylase inhibitor
12/20/2001	US20010053778 Pharmaceutical compositions of glycogen phosphorylase inhibitors
12/20/2001	US20010053777 Synergistic mixture containing alpha 2-antagonist agent and neuropsychic drug
12/20/2001	US20010053775 Nasal solutions
12/20/2001	US20010053761 Method for administering aspb28-human insulin
12/20/2001	US20010053549 Loading method
12/20/2001	US20010053391 Use of saw palmetto to prevent atherosclerosis
12/20/2001	US20010053388 Containing a bisphosphonate acid or its pharmaceutically acceptable salt dissolved in an aqueous solution, and a polymeric gel forming agent capable of inhibiting diffusion of the active ingredient with human tissue.
12/20/2001	US20010053387 Benzimidazole pharmaceutical composition and process of prepatation
12/20/2001	US20010053386 (R)-5,6-dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one maleate
12/20/2001	US20010053385 Novel formulations comprising lipid-regulating agents
12/20/2001	US20010053383 Solubility parameter based drug delivery system and method for altering drug saturation concentration
12/20/2001	US20010053375 Delivery systems for a tooth whitener
12/20/2001	US20010053373 Combining a solid dosage form and aqueous diluent in a single-use mixing and dosing cup having an abrasive interior surface and mixing to form a liquid dosage formulation.
12/20/2001	US20010053368 Proteosome influenza vaccine
12/20/2001	US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors
12/20/2001	US20010053359 Intercellular Adhesion Molecule 1 (ICAM-1) and a bioadhesive
12/20/2001	US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct.
12/20/2001	US20010053355 Treated monocytes incubated to maximize number of functional dendritic cells; then incubated with disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents.
12/20/2001	DE10120279A1 System for storing treatment parameter values in an implantable medicine pump, comprises read only memory, a non-transitory memory, and random access memory
12/20/2001	DE10029201A1 Retarded release oral dosage form, obtained by granulating mixture containing active agent and polyvinyl acetate-polyvinyl pyrrolidone mixture below the melting temperature
12/20/2001	DE10029014A1 Urokinase inhibitor, useful for treatment, prophylaxis or diagnosis of thromboembolic disease, comprising acylated 3- or 4-amidino-benzylamine derivative
12/20/2001	DE10025803A1 Polymeroberfläche mit biologisch aktiven Eigenschaften und Verfahren zu ihrer Herstellung Polymer surface with biologically active properties and processes for their preparation
12/20/2001	CA2441161A1 Method of using lectins for contraception and prophylaxis against diseases transmittable by sexual contact and condom containing lectins
12/20/2001	CA2412811A1 Process for the manufacture of hydrogel compositions and hydrogel compositions manufactured thereby
12/20/2001	CA2412343A1 Immunization through oral administration of a vaccine with an edible product
12/20/2001	CA2412165A1 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
12/20/2001	CA2409431A1 Low molecular weight polymeric compositions
12/20/2001	CA2382065A1 Bioavailable dosage form of isotretinoin
12/19/2001	EP1164132A2 Crystalline magnesium omeprazole
12/19/2001	EP1163951A2 Water-in-oil-polar solvent emulsions
12/19/2001	EP1163909A2 Use of sugar ethers as immunity adjuvant in vaccine compositions, therapeutic compositions containing them and their use as vaccine
12/19/2001	EP1163906A2 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
12/19/2001	EP1163905A1 Skin preparations for external use
12/19/2001	EP1163903A2 Methanal injection treatment for animal epidemics
12/19/2001	EP1163902A2 Transdermal preparation containing hydrophilic or salt-form drug
12/19/2001	EP1163901A1 Chewable soft capsules having improved administration properties and process for producing the same
12/19/2001	EP1163265A1 Immunogenic compounds
12/19/2001	EP1163234A1 Improved aqueous solubility pharmaceutical formulations
12/19/2001	EP1163209A1 Compounds and compositions for delivering active agents
12/19/2001	EP1163203A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
12/19/2001	EP1163009A1 Gel-microemulsion formulations
12/19/2001	EP1163008A1 Use of trehalose for stabilising a liquid vaccine
12/19/2001	EP1163007A1 Propofol formulation containing tris
12/19/2001	EP1163002A2 Polycationic carbohydrates as immunostimulants in vaccines
12/19/2001	EP1163001A2 Vaccine composition
12/19/2001	EP1162994A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
12/19/2001	EP1162989A1 Use of dictyotal extracts in the production of a topical composition
12/19/2001	EP1162988A1 Wafer delivery system
12/19/2001	EP1162984A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
12/19/2001	EP1162978A1 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
12/19/2001	EP1162975A1 Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
12/19/2001	EP1162974A1 Quinazoline formulations and therapeutic use thereof
12/19/2001	EP1162973A1 Cilostazol preparation
12/19/2001	EP1162972A2 Devices and methods for pain management
12/19/2001	EP1162969A2 Compositions for improving fertility
12/19/2001	EP1162963A1 Means for diagnosing and treating carcinoma
12/19/2001	EP1162960A2 Pharmaceutical compositions for the treatment of posttraumatic stress disorder
12/19/2001	EP1162958A1 Macromolecular pharmaceutical agent solubilized in aerosol propellant
12/19/2001	EP1162957A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
12/19/2001	EP1162956A2 Compositions and methods for improving integrity of compromised body passageways and cavities
12/19/2001	EP1162955A1 Nanoparticles, complexes with polynucleotides and their use
12/19/2001	EP1162954A1 Novel formulations comprising lipid-regulating agents
12/19/2001	EP1162953A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
12/19/2001	EP1162952A1 Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
12/19/2001	EP1162951A1 Controlled release bupropion formulation
12/19/2001	EP1162950A1 Media in the form of complex dispersions, method for preparing same and uses
12/19/2001	EP1162949A1 Urethane surfactants and their use in personal care formulations
12/19/2001	EP1162948A1 An improved reversible contraceptive for male and female
12/19/2001	EP1162946A1 Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained
12/19/2001	EP1162945A1 Particle based vaccine composition
12/19/2001	EP1162943A1 Non-stinging coating composition
12/19/2001	EP1162929A1 Compact dosage unit for buccal administration of a pharmacologically active agent
12/19/2001	EP1162883A1 Oral anti-odor compositions
12/19/2001	EP1053743B1 Composition for the treatment of halitosis
12/19/2001	EP1033978B1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
12/19/2001	EP1014916B1 Foaming skin cream, uses thereof and a method for producing the same
12/19/2001	EP0914098A4 Multi-layered osmotic device
12/19/2001	EP0906092B1 Pharmaceutical compositions based on diclofenac
12/19/2001	EP0845982B1 Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process
12/19/2001	EP0837674B1 Process for producing a layered tablet for the controlled release of active substances
12/19/2001	EP0785794B1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
12/19/2001	EP0777451B1 Ophthalmic delivery system
12/19/2001	EP0766557B1 Topical compositions comprising n-acetyl-l-cysteine
12/19/2001	EP0751785B2 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
12/19/2001	EP0705101B1 Antiparasitic compositions
12/19/2001	EP0699068B1 Reduction of liposome-induced adverse physiological reactions
12/19/2001	EP0683665B1 Magnetically responsive composition for carrying biologically active substances and methods of production and use
12/19/2001	EP0659073B1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents
12/19/2001	EP0627218B1 Process for producing fast soluble tablets and fast soluble tablets comprising xylitol

1 ... 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 ... 2991